Feed SCNI
SC
Scinai Immunotherapeutics Ltd.
SCNI · NASDAQ
$0.25 -1.88% (-$0.00)
1M -4.92%
Market Cap $340.4K
P/E Ratio -
Div. Yield -
ROE 88.72%
Bulios Fair Price
$0.35
42.7% upside
Preț actual
$0.25
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile SCNI sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Valuation
100 /100
Cheap P/B 0.04x
P/S 0.26x
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Op. margin 575.29%
Gross margin 202.29%
FCF margin 461.86%
Quality
1 /100
Poor ROA 71.45%
ROIC 72.73%
Asset turnover 0.11x
Debt
60 /100
Moderate Int. coverage -22.14x
Debt/Equity 0.28x
Current ratio 1.30x
Stability
1 /100
Unstable Profitable years 0
Beta 2.11x
EPS volatility 151.55%
Întreabă StockBot despre SCNI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Amir Reichman
Employees
45
Headquarters
Jerusalem
Evenimente viitoare
20 AUG.
Earnings
Upcoming earnings report